Here is a select list of cancer therapies approved by the regulatory agency over the last month. On Jan. 16, the FDA granted traditional approval to treatment with Calquence plus bendamustine and ...

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult pat ...

Roche Holding said the U.S. Food and Drug Administration approved a test to identify patients with a specific type of breast cancer ... possible path to HER2-targeted treatment where none existed ...

A Pfizer drug recently awarded accelerated FDA approval in colorectal ... including colorectal cancer. The drug was first approved in 2018 as a treatment for advanced cases of melanoma.

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

The designation offers several development and commercial incentives, including seven years of market exclusivity in the US following product approval and FDA assistance ... for combined diagnosis and ...